BRTX vs. OTRK, MGRX, MRAI, GBNHF, CORBF, DVA, FMS, SHC, AGL, and PGNY
Should you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Ontrak (OTRK), Mangoceuticals (MGRX), Marpai (MRAI), Greenbrook TMS (GBNHF), Global Cord Blood (CORBF), DaVita (DVA), Fresenius Medical Care (FMS), Sotera Health (SHC), agilon health (AGL), and Progyny (PGNY). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry.
Ontrak (NASDAQ:OTRK) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.
Ontrak has a net margin of -186.35% compared to Ontrak's net margin of -9,873.97%. Ontrak's return on equity of -114.84% beat BioRestorative Therapies' return on equity.
Ontrak has a beta of 2.5, meaning that its stock price is 150% more volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 62.12, meaning that its stock price is 6,112% more volatile than the S&P 500.
BioRestorative Therapies has lower revenue, but higher earnings than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.
Ontrak currently has a consensus target price of $4.00, indicating a potential upside of 1,493.63%. Given BioRestorative Therapies' higher possible upside, equities analysts plainly believe Ontrak is more favorable than BioRestorative Therapies.
13.0% of Ontrak shares are owned by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are owned by institutional investors. 1.6% of Ontrak shares are owned by company insiders. Comparatively, 21.6% of BioRestorative Therapies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.
In the previous week, Ontrak and Ontrak both had 2 articles in the media. Ontrak's average media sentiment score of 1.43 beat BioRestorative Therapies' score of 0.44 indicating that BioRestorative Therapies is being referred to more favorably in the news media.
Summary
BioRestorative Therapies beats Ontrak on 8 of the 15 factors compared between the two stocks.
Get BioRestorative Therapies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioRestorative Therapies Competitors List
Related Companies and Tools
